(Q77110252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

review article

1 reference

title

Sustained delivery of GDNF: towards a treatment for Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

A D Zurn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

H R Widmer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

P Aebischer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

222-229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

The GDNF family ligands and receptors - implications for neural development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. Network of European CNS Transplantation and Restoration (NECTAR).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Dopaminergic neurons protected from degeneration by GDNF gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Gene therapy in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Neuroprotective and neurorestorative properties of GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Parkinson's disease. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Encapsulated cells as therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Glial cell line-derived neurotrophic factor: the lateral cerebral ventricle as a site of administration for stimulation of the substantia nigra dopamine system in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Lentiviruses as gene transfer agents for delivery to non-dividing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

The GDNF protein family: gene ablation studies reveal what they really do and how.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Lentiviral vectors: turning a deadly foe into a therapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2801%2900098-4

7 January 2021

10.1016/S0165-0173(01)00098-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690619%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference